Literature DB >> 16971193

Exploiting heparin-binding properties of MoMLV-based retroviral vectors for affinity chromatography.

María de las Mercedes Segura1, Amine Kamen, Marie-Claude Lavoie, Alain Garnier.   

Abstract

Chromatography is deemed the most promising technology for large-scale purification of viral vectors. The authors have previously shown that heparin affinity chromatography could be successfully employed for the purification of VSV-G pseudotyped Moloney murine leukemia virus (MoMLV)-derived vectors giving excellent results in terms of recovery of active particles, reproducibility and selectivity. In this study, the authors examined whether the ability of retrovirus particles to specifically bind to heparin ligands is restricted to VSV-G pseudotypes produced by 293-based packaging cells. It is shown that VSV-G deficient retrovirus particles are captured by a heparin chromatography column as efficiently as VSV-G containing particles. Most strikingly, RD114 pseudotyped retrovirus particles derived from a HT1080-based cell line were found to bind heparin with the same affinity as 293-derived VSV-G pseudotypes. RD114 pseudotyped retrovirus particles were successfully isolated using heparin affinity chromatography obtaining good recoveries of functional particles (43%). These results indicate that heparin affinity chromatography can be extended to the purification of retroviral vectors produced by different packaging cell lines independently of the Env-protein used for pseudotyping.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16971193     DOI: 10.1016/j.jchromb.2006.08.032

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  5 in total

1.  Entry kinetics and cell-cell transmission of surface-bound retroviral vector particles.

Authors:  Lee S O'Neill; Amy M Skinner; Josha A Woodward; Peter Kurre
Journal:  J Gene Med       Date:  2010-05       Impact factor: 4.565

2.  Optimised concentration and purification of retroviruses using membrane chromatography.

Authors:  D J McNally; D Darling; F Farzaneh; P R Levison; N K H Slater
Journal:  J Chromatogr A       Date:  2014-03-15       Impact factor: 4.759

3.  Production and purification of high-titer foamy virus vector for the treatment of leukocyte adhesion deficiency.

Authors:  Md Nasimuzzaman; Danielle Lynn; Rebecca Ernst; Michele Beuerlein; Richard H Smith; Archana Shrestha; Scott Cross; Kevin Link; Carolyn Lutzko; Diana Nordling; David W Russell; Andre Larochelle; Punam Malik; Johannes C M Van der Loo
Journal:  Mol Ther Methods Clin Dev       Date:  2016-03-16       Impact factor: 6.698

4.  Purification of Bionanoparticles.

Authors:  L Pedro; S S Soares; G N M Ferreira
Journal:  Chem Eng Technol       Date:  2008-05-27       Impact factor: 1.728

Review 5.  Downstream processing of cell culture-derived virus particles.

Authors:  Michael W Wolf; Udo Reichl
Journal:  Expert Rev Vaccines       Date:  2011-10       Impact factor: 5.217

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.